Bacterial soft tissue infection in psoriasis despite induction of epidermal antimicrobial peptides

Experimental Dermatology

Volumn 23, Issue 11, 2014, Pages 862-864

  Steinz, Kirsten ^a   Schubert, Sabine ^a   Harder, Jürgen ^a   Gerdes, Sascha ^a   Mrowietz, Ulrich ^a   Gläser, Regine ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Antimicrobial peptides; Bacterial soft tissue infection; Psoriasis

Indexed keywords

BETA DEFENSIN 2; BETA DEFENSIN 3; CALGRANULIN A; CALGRANULIN B; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; HUMAN NEUTROPHIL PEPTIDE 1; HUMAN NEUTROPHIL PEPTIDE 2; HUMAN NEUTROPHIL PEPTIDE 3; PENICILLIN DERIVATIVE; PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; PSORIASIN; RIBONUCLEASE; RIBONUCLEASE 7; UNCLASSIFIED DRUG; BETA DEFENSIN; BETA-DEFENSIN 3, HUMAN; DEFB4A PROTEIN, HUMAN;

AGED; CASE REPORT; CONTROLLED STUDY; CORYNEBACTERIUM; CORYNEBACTERIUM TUBERCULOSTEARICUM; CUTANEOUS PARAMETERS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYSIPELAS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LETTER; LIMIT OF DETECTION; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; PSORIASIS; QUANTITATIVE ANALYSIS; SKIN BIOPSY; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS INFECTION; TISSUE LEVEL; TREATMENT DURATION; COMPLICATION; INFLAMMATION; METABOLISM; MICROBIOLOGY; SKIN; SOFT TISSUE INFECTION;

AGED; BETA-DEFENSINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYSIPELAS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; PSORIASIS; SKIN; SOFT TISSUE INFECTIONS;

EID: 84937543505     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12538     Document Type: Letter

References (25)

1. Krasagakis K, Valachis A, Maniatakis P et al. Int J Dermatol 2010: 49: 1012-1017.
2. Henseler T, Christophers E. J Am Acad Dermatol 1995: 32: 982-986.
3. Nakatsuji T, Gallo R L. J Invest Dermatol 2012: 132: 887-895.
4. Celis J E, Crüger D, Kiil J et al. Electrophoresis 1990: 11: 242-254.
5. Buchau A S, Gallo R L. Clin Dermatol 2007: 25: 616-624.
6. Gallo R L. Exp Dermatol 2013: 22: 517.
7. Lande R, Gregorio J, Facchinetti V et al. Nature 2007: 449: 564-569.
8. Ganguly D, Chamilos G, Lande R et al. J Exp Med 2009: 206: 1983-1994.
9. Gläser R, Harder J, Lange H et al. Nat Immunol 2004: 6: 57-64.
10. Nizet V, Ohtake T, Lauth X et al. Nature 2001: 414: 454-457.
11. Wittersheim M, Cordes J, Meyer-Hoffert U et al. Exp Dermatol 2013: 22: 364-366.
12. Harder J, Schröder J-M, Gläser R. Exp Dermatol 2013: 22: 1-5.
13. Harder J, Schröder J-M. J Leukoc Biol 2005: 77: 476-486.
14. Gläser R, Navid F, Schuller W et al. J Allergy Clin Immunol 2009: 123: 1117-1123.
15. Harder J, Dressel S, Wittersheim M et al. J Invest Dermatol 2010: 130: 1355-1364.
16. Laudien M, Dressel S, Harder J et al. Rhinology 2011: 49: 107-111.
17. Schmalenberger A, Tebbe C C. Methods Mol Biol 2014: 1096: 71-83.
18. Schwieger F, Tebbe C C. Appl Environ Microbiol 1998: 64: 4870-4876.
19. Wanke I, Steffen H, Christ C et al. J Invest Dermatol 2011: 131: 382-390.
20. Percoco G, Merle C, Jaouen T et al. Exp Dermatol 2013: 22: 800-806.
21. Gläser R. J Dtsch Dermatol Ges 2011: 9: 678-680.
22. Lee K C, Eckert R L. J Invest Dermatol 2007: 127: 945-957.
23. Dorschner R A, Pestonjamasp V K, Tamakuwala S et al. J Invest Dermatol 2001: 117: 91-97.
24. Dressel S, Harder J, Cordes J et al. Exp Dermatol 2010: 19: 628-632.
25. MacLeod A S, Hemmers S, Garijo O et al. J Clin Invest 2013: 123: 4364-4374.